Milk Fat Globule Epidermal Growth Factor–8 Blockade Triggers Tumor Destruction Through Coordinated Cell-autonomous and Immune-mediated Mechanisms

DSpace/Manakin Repository

Milk Fat Globule Epidermal Growth Factor–8 Blockade Triggers Tumor Destruction Through Coordinated Cell-autonomous and Immune-mediated Mechanisms

Citable link to this page

. . . . . .

Title: Milk Fat Globule Epidermal Growth Factor–8 Blockade Triggers Tumor Destruction Through Coordinated Cell-autonomous and Immune-mediated Mechanisms
Author: Jinushi, Masahisa; Sato, Marimo; Kanamoto, Akira; Itoh, Akihiko; Nagai, Shigenori; Koyasu, Shigeo; Tahara, Hideaki; Dranoff, Glenn

Note: Order does not necessarily reflect citation order of authors.

Citation: Jinushi, Masahisa, Marimo Sato, Akira Kanamoto, Akihiko Itoh, Shigenori Nagai, Shigeo Koyasu, Glenn Dranoff, and Hideaki Tahara. 2009. Milk fat globule epidermal growth factor–8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms. The Journal of Experimental Medicine 206(6): 1317-1326.
Full Text & Related Files:
Abstract: Carcinogenesis reflects the dynamic interplay of transformed cells and normal host elements, but cancer treatments typically target each compartment separately. Within the tumor microenvironment, the secreted protein milk fat globule epidermal growth factor–8 (MFG-E8) stimulates disease progression through coordinated \(\alpha_v \beta_3\) integrin signaling in tumor and host cells. MFG-E8 enhances tumor cell survival, invasion, and angiogenesis, and contributes to local immune suppression. We show that systemic MFG-E8 blockade cooperates with cytotoxic chemotherapy, molecularly targeted therapy, and radiation therapy to induce destruction of various types of established mouse tumors. The combination treatments evoke extensive tumor cell apoptosis that is coupled to efficient dendritic cell cross-presentation of dying tumor cells. This linkage engenders potent antitumor effector T cells but inhibits FoxP3\(^+\) T reg cells, thereby achieving long-term protective immunity. Collectively, these findings suggest that systemic MFG-E8 blockade might intensify the antitumor activities of existing therapeutic regimens through coordinated cell-autonomous and immune-mediated mechanisms.
Published Version: doi://10.1084/jem.20082614
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715055/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8148891

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters